Eva Guerra

Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer

Ignace Vergote, José Alejandro Pérez Fidalgo, Erika Hamilton et al. · Journal of Clinical Oncology · 2023 · 71 citations · Full text

Medicine, Oncology, Pharmacology +15

Assessment of Antihistamines and Corticosteroids as Premedication in Rapid Drug Desensitization to Paclitaxel: Outcomes in 155 Procedures

Paula López-González, Ricardo Madrigal‐Burgaleta, Laura V. Carpio-Escalona et al. · The Journal of Allergy and Clinical Immunology In Practice · 2017 · 30 citations

Life Sciences, Pharmacology, Pharmacotherapy +5

Efficacy of subsequent therapies in patients (pts) with advanced ovarian cancer (AOC) in the phase III PAOLA-1/ENGOT-ov25 trial according to whether disease progression occurred during or after the end of olaparib (ola) maintenance.

Philipp Harter, Marie‐Ange Mouret‐Reynier, Domenica Lorusso et al. · Journal of Clinical Oncology · 2023 · 29 citations

Medicine, Oncology, Pharmacology +17

Standard Versus Continuous Administration of Capecitabine in Metastatic Breast Cancer (GEICAM/2009-05): A Randomized, Noninferiority Phase II Trial With a Pharmacogenetic Analysis

Miguel Martín, Noelia Martínez-Jáñez, Manuel Ramos et al. · The Oncologist · 2015 · 24 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Evaluation of an individualized starting-dose of niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study.

Mansoor Raza Mirza, Antonio González-Martı́n, Whitney A. Spannuth Graybill et al. · Journal of Clinical Oncology · 2020 · 23 citations

Pharmacy, Oncology, Pharmacotherapy +17